A new drug for the treatment of brain tumors manufactured by Grand Pharmaceutical Group (HK: 0512) has been given the green light by Chinese regulators . . .
SIGN IN OR SUBSCRIBE TO GET FULL ACCESS.
We build ONE TIMELINE to help you keep up with China Markets!
FREE TRIAL & ONLY $4.9 FOR A MONTH!
One-click cancel any time!